Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Antithrombotics in stable peripheral artery disease.

Kaplovitch E, Rannelli L, Anand SS.

Vasc Med. 2019 Apr;24(2):132-140. doi: 10.1177/1358863X18820123. Epub 2019 Feb 24.

PMID:
30799766
2.

Antithrombotic treatment in peripheral artery disease.

Olinic DM, Tataru DA, Homorodean C, Spinu M, Olinic M.

Vasa. 2018 Feb;47(2):99-108. doi: 10.1024/0301-1526/a000676. Epub 2017 Nov 21. Review.

3.

Treatment Strategies for Patients With Peripheral Artery Disease [Internet].

Jones WS, Schmit KM, Vemulapalli S, Subherwal S, Patel MR, Hasselblad V, Heidenfelder BL, Chobot MM, Posey R, Wing L, Sanders GD, Dolor RJ.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May.

4.

Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.

Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Steg PG, Massaro JM, Apruzzese PK, Mauri L; Dual Antiplatelet Therapy Study Investigators.

JACC Cardiovasc Interv. 2017 May 8;10(9):942-954. doi: 10.1016/j.jcin.2017.02.013.

5.

Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis.

Navarese EP, Wernly B, Lichtenauer M, Petrescu AM, Kołodziejczak M, Lauten A, Frediani L, Veulemanns V, Wanha W, Wojakowski W, Lesiak M, Ferrante G, Zeus T, Tantry U, Bliden K, Buffon A, Contegiacomo G, Jung C, Kubica J, Pestrichella V, Gurbel PA.

Int J Cardiol. 2018 Oct 15;269:292-297. doi: 10.1016/j.ijcard.2018.07.009. Epub 2018 Jul 3.

PMID:
30045826
6.

A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease.

Beiswenger AC, Jo A, Harth K, Kumins NH, Shishehbor MH, Kashyap VS.

J Vasc Surg. 2018 Jun;67(6):1922-1932.e6. doi: 10.1016/j.jvs.2018.02.047. Review.

PMID:
29801560
7.

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.

Rodés-Cabau J, Masson JB, Welsh RC, Garcia Del Blanco B, Pelletier M, Webb JG, Al-Qoofi F, Généreux P, Maluenda G, Thoenes M, Paradis JM, Chamandi C, Serra V, Dumont E, Côté M.

JACC Cardiovasc Interv. 2017 Jul 10;10(13):1357-1365. doi: 10.1016/j.jcin.2017.04.014. Epub 2017 May 17.

8.

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.

Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KRH, Keltai K, Bhatt DL, Verhamme P, Fox KAA, Cook-Bruns N, Lanius V, Connolly SJ, Yusuf S.

J Am Coll Cardiol. 2018 May 22;71(20):2306-2315. doi: 10.1016/j.jacc.2018.03.008. Epub 2018 Mar 11.

PMID:
29540326
9.

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.

Bonaca MP, Bhatt DL, Storey RF, Steg PG, Cohen M, Kuder J, Goodrich E, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Dalby A, Špinar J, Aylward P, Corbalán R, Abola MTB, Jensen EC, Held P, Braunwald E, Sabatine MS.

J Am Coll Cardiol. 2016 Jun 14;67(23):2719-2728. doi: 10.1016/j.jacc.2016.03.524. Epub 2016 Apr 1.

10.

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.

Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD000535. doi: 10.1002/14651858.CD000535.pub3. Review.

PMID:
25695213
11.

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.

Robertson L, Ghouri MA, Kovacs F.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002071. doi: 10.1002/14651858.CD002071.pub3. Review.

PMID:
22895926
12.

Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.

13.

Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.

Franzone A, Piccolo R, Gargiulo G, Ariotti S, Marino M, Santucci A, Baldo A, Magnani G, Moschovitis A, Windecker S, Valgimigli M.

JAMA Cardiol. 2016 Oct 1;1(7):795-803. doi: 10.1001/jamacardio.2016.2811.

PMID:
27572001
14.

Antithrombotic Therapy in Lower Extremity Artery Disease.

Vrsalovic M, Aboyans V.

Curr Vasc Pharmacol. 2019 Feb 6. doi: 10.2174/1570161117666190206230516. [Epub ahead of print]

PMID:
30727898
15.

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators.

Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.

16.

Dual anti-platelet therapy after coronary drug-eluting stent implantation and surgery-associated major adverse events.

Egholm G, Thim T, Olesen KK, Madsen M, Sorensen HT, Jensen SE, Jensen LO, Botker HE, Kristensen SD, Maeng M.

Thromb Haemost. 2016 Jul 4;116(1):172-80. doi: 10.1160/TH15-12-0954. Epub 2016 Apr 21.

PMID:
27098806
17.

Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.

Parker WA, Storey RF.

Heart. 2016 May 15;102(10):783-9. doi: 10.1136/heartjnl-2015-307858. Epub 2016 Feb 8. Review.

PMID:
26857211
18.

[Anti-Thrombotic Treatment of Patients with Peripheral Artery Disease (PAD)].

Espinola-Klein C.

Dtsch Med Wochenschr. 2018 Aug;143(15):1060-1064. doi: 10.1055/a-0507-5565. Epub 2018 Jul 30. Review. German.

PMID:
30060273
19.

Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.

Lemesle G, Ducrocq G, Elbez Y, Van Belle E, Goto S, Cannon CP, Bauters C, Bhatt DL, Steg PG; REACH Investigators.

Clin Cardiol. 2017 Oct;40(10):932-939. doi: 10.1002/clc.22750. Epub 2017 Jul 10.

20.

Review of aspirin and clopidogrel resistance in peripheral arterial disease.

Guirgis M, Thompson P, Jansen S.

J Vasc Surg. 2017 Nov;66(5):1576-1586. doi: 10.1016/j.jvs.2017.07.065. Review.

PMID:
28893489

Supplemental Content

Support Center